Skip to main
HTFL
HTFL logo

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow Inc. has demonstrated better-than-expected revenue performance in the U.S. for its FFRct product, indicating strong demand and adoption of its innovative non-invasive solutions for coronary artery disease. The company is positioned for significant revenue growth as it anticipates increasing adoption rates for both its FFR CT Analysis and Plaque Analysis technologies. Given these positive trends and the overall expansion of the elite medical technology sector, there is a favorable outlook for HeartFlow’s stock based on its potential for continued financial improvement.

Bears say

HeartFlow has faced substantial net losses since its establishment in 2007, reporting losses of $95.7 million in FY23 and $96.4 million in FY24, with expectations of further losses in the future, raising concerns about its ability to achieve profitability. The company's reliance on healthcare providers to adopt specific guidelines for referring patients may hinder the widespread implementation of its non-invasive diagnostic solutions, as such guidelines might not gain universal acceptance. Additionally, the risk of inadequate reimbursement from third-party payors, including government insurers, could adversely impact the adoption of the HeartFlow Platform, further complicating the company's financial outlook.

HeartFlow Inc (HTFL) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 4 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.